2CHAITMAN B R,PEPINE C J,PARKER J O,et al.Effects of ranolazine with atenolol,amlodipine,or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina:a randomized controlled trial[ J ].J Am Med Assoc,2004,291:309-316.
3PEPINE C J,WOLFF A A.A controlled trial with a novel anti-ischemic agent,ranolazine,in chronic stable angina pectoris that is responsive to conventional antianginal agents[J].J Cardiol,1999,84:46-50.
4STONE P H,GRATSIANSKY N A,BLOKHIN A,et al.Antianginal efficacy of ranolazine when added to treatment with amlodipine:the ERICA (efficacy of ranolazine in chronic angina) trial[J ].J Am Coll Cardiol,2006,48:566-575.
二级参考文献1
1[1]Kluge,Arthur Frederick;Clark,Robin Douglas;Strosberg,Arthur Martin;Pascal,Jean Claude;Whiting,Roger Lewis.Cardioselective aryloxy and arylthiohydroxy propylpiperzinyl acetanilides which affect calcium entry [P].European Patent:126449,1984.
5Leea L, Horowitzb J,Michael F. Metabolic manipulation in iscbaemic heart disease, a novel approach to treatment[J]. Eur-Heart J,2004,25:634-641.
6Kennedy J A,Kiosoglous A J, Murphy G A,et al. Effect of perhexiline and oxfenicine on myocardial function and metabolism during low-flow ischemia/reperfusion in the isolated tatheart[J].J Card-invasc Pharmacol, 2000,36 (6) : 794-801.
7Grynberg A. Effectors of fatty acic oxidation reduction:promising new anti-ischaemic gaents[J].Curr Phatmt Des, 2005,11 (4) :489-509.
8Timmis A D, Chaitman B R, Crager M. Effects of ranolazine on exercise tolerance and HbAlc in patients with chronic angina and diabetes[J]. Eur Heart J, 2006, 27(1):42-48.
9Antzelevitch C, Belardinelli L, Zygmunt A C, et al. Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties[J].Circulation, 2004, 110(8):904-910.
10Stonep H, Gratsianskyn A, Blokein A, et al. Antianginal efficacy of ranolazine when added to treatment with amlodipine:the ERICA (efficacy of ranolazine in chronic angina) trial[J].J Am Coll Cardiol, 2006,48 :566-575.
